AGP Executive Report
Last update: 2 hours agoDiabetes Prevention in Focus: New EASD research from Milan reports that type 1 diabetes screening can be rolled out across Europe in children, using a harmonised approach based on islet autoantibodies, with feasibility and participation rates tested across eight countries. Diet and Diabetes: The same EASD meeting also highlights findings that very low carbohydrate diets may offer health benefits for children with type 1 diabetes without major acute complications, while researchers continue to watch for safety concerns like growth and ketoacidosis risk. Vaccines and T1D Trends: A Norway study presented at EASD found an 11% rise in type 1 diabetes incidence in ages 0.5–5 after rotavirus vaccine rollout in 2014, though secondary analyses suggest the vaccine is unlikely to be the cause. New Weight-Loss Drug Pipeline: EASD in Milan will also see early data on CBL-514, an injection designed to target fat cells and reduce both subcutaneous and visceral fat, with signals it may help limit weight regain after stopping GLP-1 medicines.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
